RAMM — Ramm Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Ramm Pharma, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.

	2019 October 31st	2020 October 31st	R2021 October 31st	R2022 October 31st	2023 October 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	Interim Report	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	35.4	28	17.2	9.77	5.12
Net Total Accounts Receivable
Net Total Receivables	1.92	1.35	3.95	2.74	1.88
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	39.2	31.2	24.3	16.7	10.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.43	2.29	19.3	19.7	19
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Total Assets	42.7	37.2	59.8	39.2	32.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.44	1.32	3.32	3.2	2.66
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	4.55	1.34	3.46	3.66	2.84
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	38.1	35.8	56.4	35.6	29.5
Total Liabilities & Shareholders' Equity	42.7	37.2	59.8	39.2	32.3
Total Common Shares Outstanding